Home Healthcare Pharmaceuticals Benign Prostatic Hyperplasia Treatment Market

Benign Prostatic Hyperplasia Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others), Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others), Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Clinics, Home Care Settings), By Distribution Channel: (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Benign Prostatic Hyperplasia Treatment Market Size Analysis
    1. Introduction
    2. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
      2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
      3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
    3. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Ambulatory Surgical Centers (ASCs)
      3. Clinics
      4. Home Care Settings
    4. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  7. North America Benign Prostatic Hyperplasia Treatment Market Size Analysis
    1. Introduction
    2. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
      2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
      3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
    3. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Ambulatory Surgical Centers (ASCs)
      3. Clinics
      4. Home Care Settings
    4. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  8. Europe Benign Prostatic Hyperplasia Treatment Market Size Analysis
    1. Introduction
    2. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
      2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
      3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
    3. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Ambulatory Surgical Centers (ASCs)
      3. Clinics
      4. Home Care Settings
    4. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    7. France
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  9. APAC Benign Prostatic Hyperplasia Treatment Market Size Analysis
    1. Introduction
    2. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
      2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
      3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
    3. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Ambulatory Surgical Centers (ASCs)
      3. Clinics
      4. Home Care Settings
    4. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    5. China
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    8. India
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  10. Middle East and Africa Benign Prostatic Hyperplasia Treatment Market Size Analysis
    1. Introduction
    2. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
      2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
      3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
    3. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Ambulatory Surgical Centers (ASCs)
      3. Clinics
      4. Home Care Settings
    4. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  11. LATAM Benign Prostatic Hyperplasia Treatment Market Size Analysis
    1. Introduction
    2. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
      2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
      3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
    3. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Ambulatory Surgical Centers (ASCs)
      3. Clinics
      4. Home Care Settings
    4. Benign Prostatic Hyperplasia Treatment Market Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
        2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
        3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
      3. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers (ASCs)
        3. Clinics
        4. Home Care Settings
      4. Market Size & Forecast By Distribution Channel: 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
  12. Competitive Landscape
    1. Benign Prostatic Hyperplasia Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Boston Scientific Corporation
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Teleflex Incorporated
    3. Olympus Corporation
    4. GlaxoSmithKline plc
    5. Pfizer Inc.
    6. Astellas Pharma Inc.
    7. Merck & Co., Inc.
    8. AbbVie Inc.
    9. Endo International plc
    10. Urologix, LLC
    11. Sanofi S.A.
    12. Asahi Kasei Corporation
    13. Medtronic plc
    14. PROCEPT BioRobotics Corporation
    15. Lumenis Ltd.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.